Logo image of ALMET.PA

METHANOR SCA (ALMET.PA) Stock Fundamental Analysis

Europe - Euronext Paris - EPA:ALMET - FR0011217710 - Common Stock

2.5 EUR
0 (0%)
Last: 11/25/2025, 7:00:00 PM
Fundamental Rating

4

Taking everything into account, ALMET scores 4 out of 10 in our fundamental rating. ALMET was compared to 74 industry peers in the Chemicals industry. ALMET has a great financial health rating, but its profitability evaluates not so good. ALMET has a valuation in line with the averages, but it does not seem to be growing.


Dividend Valuation Growth Profitability Health

Quickly go to:

2

1. Profitability

1.1 Basic Checks

ALMET had positive earnings in the past year.
ALMET had positive earnings in 4 of the past 5 years.
In the past 5 years ALMET always reported negative operating cash flow.
ALMET.PA Yearly Net Income VS EBIT VS OCF VS FCFALMET.PA Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 0 500K -500K 1M

1.2 Ratios

The Return On Assets of ALMET (2.36%) is better than 60.81% of its industry peers.
ALMET's Return On Equity of 2.43% is in line compared to the rest of the industry. ALMET outperforms 52.70% of its industry peers.
Industry RankSector Rank
ROA 2.36%
ROE 2.43%
ROIC N/A
ROA(3y)1.65%
ROA(5y)2.18%
ROE(3y)1.63%
ROE(5y)2.18%
ROIC(3y)N/A
ROIC(5y)N/A
ALMET.PA Yearly ROA, ROE, ROICALMET.PA Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2015 2016 2017 2018 2019 2020 2021 2022 2023 0 5 -5 10

1.3 Margins

The Profit Margin and Operating Margin and Gross Margin are not available for ALMET so they could not be analyzed.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM N/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
ALMET.PA Yearly Profit, Operating, Gross MarginsALMET.PA Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2015 2016 2017 2018 2019 2020 2021 2022 2023 0 -20K -40K

More info and screens

8

2. Health

2.1 Basic Checks

The number of shares outstanding for ALMET has been increased compared to 1 year ago.
ALMET has more shares outstanding than it did 5 years ago.
There is no outstanding debt for ALMET. This means it has a Debt/Equity and Debt/FCF ratio of 0 and it is amongst the best of the sector and industry.
ALMET.PA Yearly Shares OutstandingALMET.PA Yearly Shares OutstandingYearly Shares Outstanding 2015 2016 2017 2018 2019 2020 2021 2022 2023 500K 1M 1.5M 2M
ALMET.PA Yearly Total Debt VS Total AssetsALMET.PA Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2015 2016 2017 2018 2019 2020 2021 2022 2023 2M 4M 6M 8M 10M

2.2 Solvency

An Altman-Z score of 11.43 indicates that ALMET is not in any danger for bankruptcy at the moment.
ALMET's Altman-Z score of 11.43 is amongst the best of the industry. ALMET outperforms 100.00% of its industry peers.
There is no outstanding debt for ALMET. This means it has a Debt/Equity and Debt/FCF ratio of 0 and it is amongst the best of the sector and industry.
Industry RankSector Rank
Debt/Equity 0
Debt/FCF N/A
Altman-Z 11.43
ROIC/WACCN/A
WACCN/A
ALMET.PA Yearly LT Debt VS Equity VS FCFALMET.PA Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2M 4M 6M 8M 10M

2.3 Liquidity

A Current Ratio of 2.25 indicates that ALMET has no problem at all paying its short term obligations.
Looking at the Current ratio, with a value of 2.25, ALMET is in the better half of the industry, outperforming 70.27% of the companies in the same industry.
ALMET has a Quick Ratio of 2.25. This indicates that ALMET is financially healthy and has no problem in meeting its short term obligations.
The Quick ratio of ALMET (2.25) is better than 89.19% of its industry peers.
Industry RankSector Rank
Current Ratio 2.25
Quick Ratio 2.25
ALMET.PA Yearly Current Assets VS Current LiabilitesALMET.PA Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2015 2016 2017 2018 2019 2020 2021 2022 2023 500K 1M 1.5M 2M 2.5M

More info and screens

2

3. Growth

3.1 Past

The earnings per share for ALMET have decreased strongly by -81.25% in the last year.
ALMET shows a very negative growth in Earnings Per Share. Measured over the last years, the EPS has been decreasing by -13.41% yearly.
ALMET shows a very negative growth in Revenue. In the last year, the Revenue has decreased by -100.00%.
EPS 1Y (TTM)-81.25%
EPS 3Y3.64%
EPS 5Y-13.41%
EPS Q2Q%-5.56%
Revenue 1Y (TTM)-100%
Revenue growth 3YN/A
Revenue growth 5YN/A
Sales Q2Q%N/A

3.2 Future

The Earnings Per Share is expected to grow by 22.76% on average over the next years. This is a very strong growth
No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
EPS Next Y17.5%
EPS Next 2Y32.29%
EPS Next 3Y22.76%
EPS Next 5YN/A
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A

3.3 Evolution

When comparing the EPS growth rate of the last years to the growth rate of the upcoming years, we see that the growth is accelerating.
No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
ALMET.PA Yearly Revenue VS EstimatesALMET.PA Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2014 2015 2016 2017 2018 2021 2022 0 20K 40K 60K
ALMET.PA Yearly EPS VS EstimatesALMET.PA Yearly EPS VS EstimatesYearly EPS VS Estimates 2018 2019 2020 2021 2022 2023 2024 2025 2026 0 0.2 -0.2 0.4 -0.4

More info and screens

4

4. Valuation

4.1 Price/Earnings Ratio

ALMET is valuated rather expensively with a Price/Earnings ratio of 20.83.
The rest of the industry has a similar Price/Earnings ratio as ALMET.
Compared to an average S&P500 Price/Earnings ratio of 25.98, ALMET is valued at the same level.
ALMET is valuated reasonably with a Price/Forward Earnings ratio of 10.33.
ALMET's Price/Forward Earnings ratio is rather cheap when compared to the industry. ALMET is cheaper than 86.49% of the companies in the same industry.
Compared to an average S&P500 Price/Forward Earnings ratio of 35.79, ALMET is valued rather cheaply.
Industry RankSector Rank
PE 20.83
Fwd PE 10.33
ALMET.PA Price Earnings VS Forward Price EarningsALMET.PA Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 50 100 150 200 250

4.2 Price Multiples

Industry RankSector Rank
P/FCF N/A
EV/EBITDA N/A
ALMET.PA Per share dataALMET.PA EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 1 2 3 4 5

4.3 Compensation for Growth

The PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates a correct valuation of the company.
ALMET's earnings are expected to grow with 22.76% in the coming years. This may justify a more expensive valuation.
PEG (NY)1.19
PEG (5Y)N/A
EPS Next 2Y32.29%
EPS Next 3Y22.76%

More info and screens

6

5. Dividend

5.1 Amount

ALMET has a Yearly Dividend Yield of 4.72%, which is a nice return.
ALMET's Dividend Yield is rather good when compared to the industry average which is at 3.18. ALMET pays more dividend than 82.43% of the companies in the same industry.
ALMET's Dividend Yield is rather good when compared to the S&P500 average which is at 2.41.
Industry RankSector Rank
Dividend Yield 4.72%

5.2 History

The dividend of ALMET decreases each year by -10.61%.
Dividend Growth(5Y)-10.61%
Div Incr Years0
Div Non Decr Years0
ALMET.PA Yearly Dividends per shareALMET.PA Yearly Dividends per shareYearly Dividends per share 2018 2019 2020 2021 2023 0.05 0.1 0.15 0.2

5.3 Sustainability

DPN/A
EPS Next 2Y32.29%
EPS Next 3Y22.76%
ALMET.PA Yearly Income VS Free CF VS DividendALMET.PA Yearly Income VS Free CF VS DividendYearly Income VS Free CF VS Dividend 2015 2016 2017 2018 2019 2020 2021 2022 2023 0 500K -500K 1M

More info and screens

METHANOR SCA

EPA:ALMET (11/25/2025, 7:00:00 PM)

2.5

0 (0%)

Chartmill FA Rating
GICS SectorMaterials
GICS IndustryGroupMaterials
GICS IndustryChemicals
Earnings (Last)10-15 2025-10-15
Earnings (Next)04-28 2026-04-28
Inst Owners12.4%
Inst Owner ChangeN/A
Ins OwnersN/A
Ins Owner ChangeN/A
Market Cap6.05M
Revenue(TTM)N/A
Net Income(TTM)300.00K
Analysts86.67
Price Target5.44 (117.6%)
Short Float %N/A
Short RatioN/A
Dividend
Industry RankSector Rank
Dividend Yield 4.72%
Yearly Dividend0.15
Dividend Growth(5Y)-10.61%
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)0%
PT rev (3m)0%
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)0%
EPS NY rev (3m)0%
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)N/A
Revenue NY rev (3m)N/A
Valuation
Industry RankSector Rank
PE 20.83
Fwd PE 10.33
P/S N/A
P/FCF N/A
P/OCF N/A
P/B 0.49
P/tB 0.49
EV/EBITDA N/A
EPS(TTM)0.12
EY4.8%
EPS(NY)0.24
Fwd EY9.68%
FCF(TTM)N/A
FCFYN/A
OCF(TTM)N/A
OCFYN/A
SpS0
BVpS5.11
TBVpS5.11
PEG (NY)1.19
PEG (5Y)N/A
Graham Number3.72
Profitability
Industry RankSector Rank
ROA 2.36%
ROE 2.43%
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) N/A
GM N/A
FCFM N/A
ROA(3y)1.65%
ROA(5y)2.18%
ROE(3y)1.63%
ROE(5y)2.18%
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexgc growth 3YN/A
ROICexgc growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
F-ScoreN/A
Asset Turnover0
Health
Industry RankSector Rank
Debt/Equity 0
Debt/FCF N/A
Debt/EBITDA N/A
Cap/Depr N/A
Cap/Sales N/A
Interest Coverage N/A
Cash Conversion N/A
Profit Quality N/A
Current Ratio 2.25
Quick Ratio 2.25
Altman-Z 11.43
F-ScoreN/A
WACCN/A
ROIC/WACCN/A
Cap/Depr(3y)N/A
Cap/Depr(5y)N/A
Cap/Sales(3y)N/A
Cap/Sales(5y)N/A
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-81.25%
EPS 3Y3.64%
EPS 5Y-13.41%
EPS Q2Q%-5.56%
EPS Next Y17.5%
EPS Next 2Y32.29%
EPS Next 3Y22.76%
EPS Next 5YN/A
Revenue 1Y (TTM)-100%
Revenue growth 3YN/A
Revenue growth 5YN/A
Sales Q2Q%N/A
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A
EBIT growth 1Y-500%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next YearN/A
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1YN/A
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1YN/A
OCF growth 3YN/A
OCF growth 5YN/A

METHANOR SCA / ALMET.PA FAQ

What is the ChartMill fundamental rating of METHANOR SCA (ALMET.PA) stock?

ChartMill assigns a fundamental rating of 4 / 10 to ALMET.PA.


What is the valuation status for ALMET stock?

ChartMill assigns a valuation rating of 4 / 10 to METHANOR SCA (ALMET.PA). This can be considered as Fairly Valued.


Can you provide the profitability details for METHANOR SCA?

METHANOR SCA (ALMET.PA) has a profitability rating of 2 / 10.


What is the valuation of METHANOR SCA based on its PE and PB ratios?

The Price/Earnings (PE) ratio for METHANOR SCA (ALMET.PA) is 20.83 and the Price/Book (PB) ratio is 0.49.